Refine by
748 results found
-
Regulatory Comment to HHS on Health Coverage
Regulatory comment to Secretary Becerra and Administrator Brooks-LaSure in support of the Notice of Benefit and Payment Parameters for 2026 Proposed Rule, and offering comments to strengthen the rule. -
Letter to Congressional Leadership on Mental Health Funding
Letter to House and Senate Leadership urging the passage of full funding for the FY25 Appropriations Package and the reauthorization of the SUPPORT Act, in an end-of-year omnibus. -
Regulatory Comment on Medication Access
Regulatory comment encouraging FDA to remove barriers to care by allowing patients the choice to opt out of the Clozapine Risk Evaluation and Mitigation Strategy (REMS) after the initial highest risk period and to allow for emergency prescriptions when the administrative barriers are not met. -
Letter to Congressional Committee Leadership on Mental Health Funding and Crisis Services
Letter to House and Senate Appropriations Committees in support of robust FY25 funding for the Comprehensive Suicide Prevention Program under the CDC’s National Center for Injury Prevention and Control. -
Amicus Brief on Health Coverage, Mental Health Funding and Health Equity
Amicus brief in Braidwood v. Becerra, urging the courts to safeguard critical ACA protections on preventative care. -
Advocacy Resource on Medicaid and Medication Access
Advocacy resource providing open enrollment information for Medicare prescription drug coverage (Part D). -
Letter to Congressional Committee Leadership on Parity and Mental Health Funding
Letter to House and Senate Appropriations Committees requesting $15 million for the Employee Security Benefits Administration (EBSA) in the Labor-HHS appropriations bill for FY 2025 to review health plans’ parity compliance analyses. -
Letter to Congressional Committee Leadership on Child and Adolescent Mental Health and Mental Health Funding
Letter to Senate and House Appropriations Committees expressing appreciation for the inclusion of Family Resource Center (FRC) language within the Social Services Block Grant and requesting the Senate language on FRCs be included in the final Consolidated Appropriations Act for FY 2025 package. -
Study Finds Rates of Anxiety and Depression Still Higher Compared to Pre-COVID
Researchers compared rates of anxiety and depression among U.S. adults before, during, and after the pandemic using baseline data from the National Health Interview Survey and COVID-era data from the CDC Household Pulse Survey.
-
Learning More About Clinical Experiences Related to Schizophrenia
The U.S. Mental and Substance Use Disorders Prevalence Study (MDPS) was a landmark research effort designed to provide updated prevalence estimates for mental health conditions – including schizophrenia spectrum conditions – in U.S. adults. In this study, researchers used MDPS data to better understand characteristics associated with schizophrenia spectrum conditions.